Elsevier

Epilepsy Research

Volume 96, Issues 1–2, September 2011, Pages 185-189
Epilepsy Research

Short communication
Effects of acetazolamide on epileptic apnea in migrating partial seizures in infancy

https://doi.org/10.1016/j.eplepsyres.2011.05.007Get rights and content

Summary

We report two cases of migrating partial seizures in infancy complicated with intractable epileptic apnea with severe desaturation. Ictal electroencephalography revealed migrating foci of epileptiform discharges, which spread to bilateral temporal areas resulting in the onset of apnea. Magnetoencephalography detected dipole sources at bilateral perisylvian areas. Single photon emission tomography revealed a significant ictal change in perfusion at bilateral anterior temporal lobes in one patient. Addition of acetazolamide to the regimen resulted in complete disappearance of epileptic seizures.

Introduction

Migrating partial seizures in infancy (MPSI) is a rare epileptic syndrome characterized by onset before six months of age, continuous migrating polymorphous focal seizures, ictal epileptic discharges arising independently and sequentially from both hemispheres, marked intractability to antiepileptic drugs, and developmental arrest after the onset of disease (Coppola et al., 1995, Caraballo et al., 2008). Autonomic manifestations including apnea, flushing, and cyanosis often accompany or predominate the ictal phenomena (Coppola et al., 1995, Caraballo et al., 2008). Apnea as a manifestation of epileptic seizures is also observed in patients with localization-related epilepsy (Watanabe et al., 1982, Akaike et al., 2008). This type of seizure can appear during sleep or wakefulness, can necessitate resuscitation and can also be lethal (Ramelli et al., 1998), and has been assumed to be partly responsible for sudden unexpected death in epilepsy. Within these seizures, ictal activity usually consists of rhythmic focal alpha to theta activity originating in the temporal lobes (Watanabe et al., 1982). Limbic structures are densely connected to the respiratory center in the brainstem, primarily through ipsilateral descending pathways (Hopkins and Holstege, 1978). Therefore, bilateral temporal lobe involvement is significantly linked to ictal desaturation during complex partial seizures in temporal lobe epilepsy (Seyal and Bateman, 2009).

Here we report two cases of infants with MPSI who suffered from intractable epileptic apnea accompanying ictal discharges of bilateral temporal areas. Acetazolamide (AZA) administration produced significant effects on these seizures, which is the first demonstration of its usefulness in the treatment of MPSI.

Section snippets

Patient 1

The one-year-old girl was born uneventfully and at term. Growth and development were normal until six months of age, when she experienced recurrent episodes of motion arrest and subsequent cyanosis with or without clonic movements of the upper limbs beginning on the right side. Although no abnormality was noted on interictal electroencephalogram (EEG), valproate (VPA) treatment was initiated. Blood and urine analyses found no evidence of metabolic disorders, and computed tomography (CT) of the

Discussion

Epileptic apnea without convulsive symptoms can be regarded as a type of complex partial seizure (Watanabe et al., 1982). Apart from patients with neonatal seizures, this type of seizure has been mainly observed in infancy. Because decreased consciousness is often difficult to assess precisely at this age, accompanying motion arrest and minor signs such as grimacing, drooling, or flushing provide clues to the diagnosis of epilepsy. EEG reveals that these seizures most frequently originate in

References (12)

There are more references available in the full text version of this article.

Cited by (9)

  • Neonatal Epileptic Encephalopathies

    2021, Seminars in Pediatric Neurology
    Citation Excerpt :

    Treatment is challenging but the authors of case reports suggest success using a stepwise therapeutic approach utilizing levetiracetam, then a benzodiazepine such as clonazepam, and then stiripentol.43 Other groups report seizure control with phenytoin, levetiracetam, and acetazolamide,8 the last of which is especially beneficial for apneic seizures.44 Prognosis is generally poor with refractory seizures, neuro-devastation, and death within a few years.43

  • Epileptic apnea in a patient with inherited glycosylphosphatidylinositol anchor deficiency and PIGT mutations

    2018, Brain and Development
    Citation Excerpt :

    Experimental evidence indicates the presence of dense interconnections between the limbic system and respiratory center in the brainstem [3]. Moreover, ictal electroencephalography (EEG) has suggested that epileptic apnea can be caused by epileptic discharges originating in the temporal lobes [4]. Here, we presented a case of with inherited GPI anchor deficiency and compound PIGT mutations, presenting with refractory epileptic apnea.

  • Usefulness of ketogenic diet in a girl with migrating partial seizures in infancy

    2016, Brain and Development
    Citation Excerpt :

    However, similar to our case, some patients suffer from severe adverse effects such as bromoderma and over-sedation [2,6]. Favorable responses to stiripentol [1,7], acetazolamide [8], and rufinamide [9] have also been reported. In the present case, however, we selected a ketogenic diet preferentially, because the patient already suffered from severe adverse effects of KBr, and we were concerned about further adverse effects of antiepileptic drugs.

  • Malignant migrating partial seizures in infancy

    2013, Handbook of Clinical Neurology
    Citation Excerpt :

    In two other children, a combination of sodium bromide, stiripentol, and levetiracetam led to a significant therapeutic response (Djuric et al., 2011). Further, rufinamide (Vendrame et al., 2011) and acetazolamide (Irahara et al., 2011) showed a potential efficacy in a few patients. Vigabatrin and carbamazepine may worsen seizure recurrence (Dulac, 2005).

  • Medication-resistant epilepsy syndromes in children

    2020, Medication-Resistant Epilepsy: Diagnosis and Treatment
View all citing articles on Scopus
View full text